Cardiometabolic Disorders News

The American Diabetes Association announced updates to its 2022 Standards of Medical Care in Diabetes to reflect new data on cardiovascular outcomes with diabetes and kidney disease and use of SGLT2 inhibitors.

People with type 2 diabetes who achieved recommended targets for HbA1c, systolic blood pressure, LDL cholesterol and BMI had increased life expectancy, although the size of increase differed among the biomarkers, concluded recent research.

Many patients who cardiologists see have obesity, which has become widely prevalent in the United States.

Women with more visceral adipose tissue during menopause transition have worse HDL metrics, and insulin resistance is a mediating factor in some of the associations, according to study data.

Menopausal women tend to have worse cardiovascular risk profiles than premenopausal women, but 5-year increases in CV risk factors are not dependent on reproductive stage, according to data from the CoLaus study.

For patients with type 2 diabetes, first-line SGLT2 inhibitors might be better than metformin when it comes to their cardiovascular health, according to results of a population-based cohort study.

Compared with conventional treatment, bariatric surgery was superior in achieving remission of prediabetes and type 2 diabetes and reducing cardiometabolic risks for patients with obesity, researchers reported in Obesity Medicine.

In adults with prediabetes, metformin and lifestyle interventions decreased the likelihood of type 2 diabetes development but did not reduce risk for major adverse CV events compared with placebo during 21 years of follow-up, data show.

The proportion of deaths attributed to COVID-19 in people with diabetes in the U.S. in the last 3 months of 2020 was slightly higher than the percentage of people who died due to cardiovascular disease or diabetes, according to study data.

SAN DIEGO — Women with Sheehan’s syndrome and growth hormone deficiency have higher total cholesterol and triglycerides and higher inflammatory markers compared with healthy adults, according to a speaker.